Speakers

• David E. Barton, Ph.D., Chair, Board of Management, EMQN: European Molecular Genetics Quality Network; Chief Scientist, National Centre for Medical Genetics, Our Lady’s Children’s Hospital, Crumlin, Ireland, United Kingdom
• N. Reginald Beer, Ph.D., Medical Diagnostics Initiative Leader, Center for Micro and Nanotechnologies, Lawrence Livermore National Laboratory, United States
• Conceição Bettencourt, Ph.D., Research Associate, Molecular Neuroscience, Institute of Neurology, University College London, United Kingdom
• Ignacio Blanquer, Ph.D., Associate Professor/Researcher, Computer Systems/Institute of Instrumentation for Molecular Imaging, Universitat Politècnica de València, Spain
• Niklas Blomberg, Ph. D., ELIXIR Director, ELIXIR Hub, EMBL-EBI, United Kingdom
• Burkhard Brandt, Ph.D., Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany
• Keith Brown, Ph.D., Reader, Molecular Pathology, School of Cellular & Molecular Medicine, University of Bristol, United Kingdom
• Stuart Brown, Ph.D., Associate Professor, Cell Biology; Director, Sequencing Informatics Group of Center for Health Informatics & Bioinformatics; Operating Director, Best Practices Integrative Informatics Consultation Service; NYU School of Medicine, United States
• Han G. Brunner, Ph.D., Medical Geneticist, Radboud University Nijmegen Medical Centre, Netherlands
• Anne Cambon-Thomsen, M.D., Director, Research, Centre National de la Recherche Scientifique (CNRS), France
• Christopher Campbell, West Midlands Regional Genetics Laboratory, Birmingham Women’s Hospital, United Kingdom
• Ángel Carracedo, Ph.D., Director, Fundación Galega de Medicine Xenómica (FPGMX), Hospital Clínico Universitario, Spain
• Wei Chen, Ph.D., Senior Scientist and Group Leader, The Berlin Institute for Medical Systems Biology, Max Delbruck Center for Molecular Medicine, Germany
• Philippe Corbisier, Ph.D., Scientific and Technical Project Manager, Standards for Innovation and Sustainable Development, European Commission - JRC - IRMM, Belgium
• Gianmauro Cuccuru, Ph.D., Researcher, CRS4 Bioinformatics Laboratory, Italy
• Marcel Dinger, Ph.D., Head, Clinical Genomics, Centre for Clinical Genomics, Garvan Institute of Medical Research, Australia
• François Fuks, Ph.D., Director, Laboratory of Cancer Epigenetics, Faculty of Medicine, Free University of Brussels, Belgium
• Eduardo Gonzalez-Couto, Ph.D., CSO, Integromics, Spain 
• Philip Groth, Ph.D., IT Business Partner, CoE Research, Bayer HealthCare Pharmaceuticals, Germany
• Brian Haas, Manager, Genome Annotation, Outreach, Bioinformatics and Analysis, The Broad Institute of MIT and Harvard, United States
• Per Hansen, Technical Specialist, EMEA, Aspera, Inc.
• Monika E. Hegi, Ph.D., Head, Laboratory of Tumor Biology & Genetics, Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
• Heidi Carmen Howard, Ph.D., Assistant Professor, Biomedical Ethics, IQ Healthcare, Radboud University Medical Centre, Netherlands and Senior Research Fellow, Département d’épidémiologie et de Santé Publique, INSERM, Faculté de Médecine, Université Toulouse, France
• Tim Hubbard, Ph.D., Senior Group Leader, Wellcome Trust Sanger Institute, United Kingdom
• Curtis Hughesman, Ph.D., Post-Doctoral Research Fellow, Michael Smith Laboratories, University of British Columbia, Canada
• Rubén Jiménez, Chief Software Architect, R&D Division, Icinetic, Spain
• Jan D. H. Jongbloed, Ph.D., Department of Genetics, University of Groningen, University Medical Centre Groningen, Netherlands
• Guy Kiddle, Ph.D., Senior Molecular Biologist, IVD Technologies, Lumora Ltd., United Kingdom
• Rainer König, Ph.D., Professor & Group Head, Network Modeling, Eilslabs, Divisions of Theoretical Bioinformatics, German Cancer Research Center and the Department Bioinformatics and Functional Genomics, Heidelberg University, Germany
• Janis E. Landry-Lane, Program Director, World Wide High Performance Technical Computing, Life Sciences/Higher Education Segments, IBM
• Melanie Lehman, Ph.D., Research Fellow, Australian Prostate Cancer Research Centre-Queensland, Queensland University of Technology, Australia/Canada
• Guro Elisabeth Lind, Ph.D., Head, Epigenetics, Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Norway
• Steve Lincoln, Senior Vice President, Scientific Applications, InVitae, United States
• Gholson J. Lyon, M.D., Ph.D., Assistant Professor, Human Genetics, Cold Spring Harbor Laboratory and Research Scientist, Utah Foundation for Biomedical Research, United States
• Richard Meehan, Ph.D., Senior Scientist, Chromosomes and Gene Expression, Medical Research Council, The Human Genetics Unit (HGU), Western General Hospital, United Kingdom
• Hector Miras, Medical Physicist, Medical Physics, Virgen Macarena University Hospital, Spain
• Paolo Missier, Ph.D., Lecturer, Information and Knowledge Management, School of Computing Science, Newcastle University, United Kingdom
• Carla Oliveira, Ph.D., Head, Expression Regulation, Cancer Group, IPATIMUP, Portugal
• Vicente Jose Pelechano, Ph.D., Senior Scientist, Steinmetz Group, Systems Genetics, Genome Biology, European Molecular Biology Laboratory, Germany
• German Pihan, M.D., Staff Pathologist and Director, Hematopathology Service, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, United States
• Benno Pütz, Ph.D., Statistical Genetics, Max Planck Institute of Psychiatry, Germany
• Brent Richter, Executive Director, Enterprise Research Infrastructure & Services, Information Systems & Academic Programs, Partners HealthCare & Massachusetts General Hospital/Brigham & Women’s Hospital, United States
• Peter N. Robinson, M.D., Institute for Medical Genetics and Human Genetics, Humboldt-Universität, Charité-Universitätsmedizin Berlin, Germany
• Dimitrios Roukos, Centre for Biosystems & Genomic Network Medicine, Ioannina University, Greece
• Gaia Schiavon, Ph.D., Clinical Fellow, Breast Unit, The Royal Marsden NHS Foundation Trust, United Kingdom
• Alexander Schramm, Ph.D., Lab Head, Oncology Research, Children’s Hospital, University Hospital Essen, Germany
• Amnon Shabo, Ph.D., Project Leader, IBM Healthcare & Life Sciences Standards Program, IBM Haifa Research Lab
• Rolf Skotheim, Ph.D., Group Leader, Genome Biology, Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Norway
• David I. Smith, Ph.D., Professor, Department of Laboratory Medicine and Pathology; Chairman, Technology Assessment Committee, Center for Individualized Medicine, Mayo Clinic, United States
• Andrew Stubbs, Ph.D., Assistant Professor, Bioinformatics, Erasmus University Medical Center, The Netherlands
• Zoltan Szallasi, M.D., Senior Research Scientist, Children’s Hospital Informatics Program, Harvard Medical School, United States; Professor, Department of Systems Biology, Danish Technical University, Denmark
• Jesper Tegnér, Ph.D., M.D., Professor, Strategic Chair, Computational Medicine and Director, Unit of Computational Medicine, Center for Molecular Medicine, Medicine, Karolinska Institutet and Karolinska University Hospital, Sweden
• Christina Thirwell, Ph.D., Senior Lecturer & Medical Oncologist, University College London, United Kingdom
• Weida Tong, Ph.D., Division Director, Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, FDA, United States
• Tzy-Hwa (Kathy) Tzeng, Ph.D., Senior Technical Staff Member, IBM Life Science and NGS Solution
• Elizabeth Worthey, Ph.D., Human and Molecular Genetics Center, The Medical College of Wisconsin, United States